Monday 14th November

• Overview: Global BioBusiness
  J. Zuercher, Ernst & Young SA

• Assessing Technology & Market Opportunities
  S. Mehta, Rensselaer Polytechnic Institute

• BioProject: Participants' Projects

• How to Turn Biomedical Research into Commercial Value: The ESBATech Case
  A. Barberis, Biotech Entrepreneur and Executive

• Start-up an Opportunity
  S. Mehta, Rensselaer Polytechnic Institute

• Start-up Phase & Opportunity Recognition: The Addex and Inflamalps Cases
  V. Mutel, InflamAlps

• BioProject: Participants' Projects

• Apéro

 

Tuesday 15th November

• Preclinical Studies
  S. Berardi Vilei, SAKK

• Clinical Drug Development
  R. Fariello, BioNeuroFar SA

• BioProject: Participants' Projects

• Start-up BioVentures: Evax and NBE Therapeutics
  A. Fettelschoss, Evax and R. Beerli, NBE Therapeutics

• Transformation of a Powerful Technology to a Strong Business Case
  H.K. Binz, Molecular Partners

• BioProject: Participants' Projects

 

Wednesday 16th November

• Intellectual Property Rights
  P. Felder, Schmauder & Partner AG

• BioProject: Participants' Projects

• Fundamentals of Sales & Marketing
  R. Cervini, Helsinn Advanced Synthesis SA and D. Marino, CUTISS

• BioProject: Participants' Projects

• Principles of Project Valuation
  A. Plazzi, IFin, USI

• Valuation & Negotiation in Life Sciences
  A. Peire, Venture Valuation

• Evening Event

 

Thursday 17th November

• Venture Capital for Early-Stage Opportunities
  R. Fleck, Medicxi Ventures

• Registration in Europe
  U. Granzer, Granzer Regulatory Consulting & Services

• BioProject: Participants' Projects

• Business Plan
  U. Grawunder, NBE Therapeutics

• Stages of the Investment Process
  J.-P. Tripet, Aravis SA

• Apéro

• BioProject: Participants' Projects

 

Friday 18th November

• M&A: Expansion Strategy for Pharma Companies and Exit Strategy for Biotech Enterprises
  R. Braglia, Helsinn Group

• Farma Industria Ticino (FIT)
  G. Calderari, Helsinn Group and FIT

• BioProject: Participants' Projects

• Support Programs and Business Angels in Switzerland
  P. Harboe-Schmidt, CTI Start-up

• A Well Kept Secret: Successful Investments, a VC Point of View
  E. Braglia, Onelife SA

• Participants' Presentations
  and Helsinn Award for the Best BioProject

• Feedback and closing remarks